1
/
of
0
FDA Drug Approval, A215713, TRETINOIN
FDA Drug Approval, A215713, TRETINOIN
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
ANDA: 215713
Company: TARO
Drug Name: TRETINOIN
Active Ingredients: TRETINOIN
Strength: 0.025%
Dosage Form/Route: CREAM;TOPICAL
Action Date: 01/05/2023
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Company: TARO
Drug Name: TRETINOIN
Active Ingredients: TRETINOIN
Strength: 0.025%
Dosage Form/Route: CREAM;TOPICAL
Action Date: 01/05/2023
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details